Published in Curr Med Chem on January 01, 2007
IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice. J Clin Invest (2008) 1.55
Viral defense, carcinogenesis and ISG15: novel roles for an old ISG. Cytokine Growth Factor Rev (2007) 1.29
HtrA serine proteases as potential therapeutic targets in cancer. Curr Cancer Drug Targets (2009) 1.25
Spaceflight effects on T lymphocyte distribution, function and gene expression. J Appl Physiol (1985) (2008) 1.16
Regulating type 1 IFN effects in CD8 T cells during viral infections: changing STAT4 and STAT1 expression for function. Blood (2012) 1.09
Treating tumors with a vaccinia virus expressing IFNβ illustrates the complex relationships between oncolytic ability and immunogenicity. Mol Ther (2011) 1.06
Association of IFN-gamma signal transduction defects with impaired HLA class I antigen processing in melanoma cell lines. Clin Cancer Res (2011) 1.04
Interferon-β induces cellular senescence in cutaneous human papilloma virus-transformed human keratinocytes by affecting p53 transactivating activity. PLoS One (2012) 0.94
IFN-beta sensitizes neuroblastoma to the antitumor activity of temozolomide by modulating O6-methylguanine DNA methyltransferase expression. Mol Cancer Ther (2008) 0.86
Antitumorigenic effect of interferon-β by inhibition of undifferentiated glioblastoma cells. Int J Oncol (2015) 0.75
The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet (1989) 5.09
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet (1994) 4.11
Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet (1998) 3.94
A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature (1994) 3.87
SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet (1998) 3.82
Report of the committee on the genetic constitution of the X chromosome. Cytogenet Cell Genet (1989) 3.37
Mapping through somatic cell hybrids and cDNA probes of protein C to chromosome 2, factor X to chromosome 13, and alpha 1-acid glycoprotein to chromosome 9. Hum Genet (1986) 2.84
Non-inactivation of an x-chromosome locus in man. Science (1979) 2.74
Different TBX5 interactions in heart and limb defined by Holt-Oram syndrome mutations. Proc Natl Acad Sci U S A (1999) 2.70
Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci (2000) 2.06
A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet (1998) 1.81
A gene for Hirschsprung disease maps to the proximal long arm of chromosome 10. Nat Genet (1993) 1.79
Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet (2001) 1.68
Genetic inactivation of the alpha-galactosidase locus in carriers of Fabry's disease. Science (1970) 1.61
Physical mapping of the human chromosome 11q23 region containing the ataxia-telangiectasia locus. Cancer Genet Cytogenet (1990) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Phenotypic intrafamilial heterogeneity in cystic fibrosis. Clin Genet (1993) 1.53
Serotonin 5-HT3 and 5-HT4 ligands: an update of medicinal chemistry research in the last few years. Curr Med Chem (2010) 1.45
Recombinations between IRP and cystic fibrosis. Am J Hum Genet (1988) 1.44
Incidence of Friedreich ataxia in Italy estimated from consanguineous marriages. Am J Hum Genet (1983) 1.44
Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet (1997) 1.42
CD28 as a molecular amplifier extending TCR ligation and signaling capabilities. Immunity (2001) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Incidence in Italy, genetic heterogeneity, and segregation analysis of cystic fibrosis. Am J Hum Genet (1985) 1.41
Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am J Pathol (2000) 1.39
Use of BICAP in a case of colon angiodysplasia. Surg Endosc (1991) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication. Virology (1990) 1.38
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Fucosidosis revisited: a review of 77 patients. Am J Med Genet (1991) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Isolation and characterization of a steroid sulfatase cDNA clone: genomic deletions in patients with X-chromosome-linked ichthyosis. Proc Natl Acad Sci U S A (1987) 1.30
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Progress in the development of selective nitric oxide synthase (NOS) inhibitors. Curr Pharm Des (2002) 1.26
Uroporphyrinogen 3 cosynthetase in human congenital erythropoietic porphyria. Proc Natl Acad Sci U S A (1969) 1.21
RET mutations in human disease. Trends Genet (1996) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
HIV-1 Nef activates STAT1 in human monocytes/macrophages through the release of soluble factors. Blood (2001) 1.18
Uroporphyrinogen decarboxylase from mouse spleen. Biochim Biophys Acta (1971) 1.16
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Localization of a gene responsible for autosomal recessive demyelinating neuropathy with focally folded myelin sheaths to chromosome 11q23 by homozygosity mapping and haplotype sharing. Hum Mol Genet (1996) 1.13
Double heterozygosity for a RET substitution interfering with splicing and an EDNRB missense mutation in Hirschsprung disease. Am J Hum Genet (1999) 1.12
Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different origins. Mol Endocrinol (1998) 1.11
Mapping of human cellular retinol-binding protein to chromosome 3. Cytogenet Cell Genet (1986) 1.08
Volume-sensitive chloride currents in four epithelial cell lines are not directly correlated to the expression of the MDR-1 gene. J Biol Chem (1994) 1.08
Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium. J Clin Endocrinol Metab (1999) 1.07
Molecular cloning and mapping of a human cDNA (PA2G4) that encodes a protein highly homologous to the mouse cell cycle protein p38-2G4. Cytogenet Cell Genet (1997) 1.07
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Chinese patients with sporadic Hirschsprung's disease are predominantly represented by a single RET haplotype. J Med Genet (2003) 1.07
Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence. Int Angiol (2005) 1.06
Isolation of interferon-resistant variants of Friend erythroleukemia cells: effects of interferon and ouabain. Virology (1982) 1.06
Genetic mapping to 10q23.3-q24.2, in a large Italian pedigree, of a new syndrome showing bilateral cataracts, gastroesophageal reflux, and spastic paraparesis with amyotrophy. Am J Hum Genet (1999) 1.06
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Stability of X chromosomal inactivation in human somatic cells transformed by SV-40. Humangenetik (1975) 1.04
Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism. Diabetes (1997) 1.04
The neonatal management and surgical correction of urinary hydrometrocolpos caused by a persistent urogenital sinus. BJU Int (1999) 1.03
CD28 utilizes Vav-1 to enhance TCR-proximal signaling and NF-AT activation. J Immunol (2000) 1.03
Modulation of ferritin H-chain expression in Friend erythroleukemia cells: transcriptional and translational regulation by hemin. Mol Cell Biol (1992) 1.03
Partial digestion with restriction enzymes of ultraviolet-irradiated human genomic DNA: a method for identifying restriction site polymorphisms. Genomics (1988) 1.03
Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence. J Clin Endocrinol Metab (1996) 1.02
Aryl hydrocarbon receptor knockout mice (AHR-/-) exhibit liver retinoid accumulation and reduced retinoic acid metabolism. Cancer Res (1997) 1.01
Frequency of RET mutations in long- and short-segment Hirschsprung disease. Hum Mutat (1997) 1.01
Phenotypic diversity, allelic series and modifier genes. Nat Genet (1994) 1.00
Genotype-phenotype correlation and germline mosaicism in DMD/BMD patients with deletions of the dystrophin gene. Hum Genet (1991) 1.00
Incidence of classic PKU in Italy estimated from consanguineous marriages and from neonatal screening. Clin Genet (1983) 1.00
Mucocele of the appendix. Two case reports. G Chir (2012) 1.00
Screening for non-delta F508 mutations in five exons of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in Italy. Am J Hum Genet (1991) 1.00
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH. Cytogenet Cell Genet (2000) 0.99
Single nucleotide polymorphic alleles in the 5' region of the RET proto-oncogene define a risk haplotype in Hirschsprung's disease. J Med Genet (2003) 0.99
Mosaicism for sulfoiduronate sulfatase deficiency in carriers of Hunter's syndrome. Experientia (1976) 0.99
Frequency of the delta F508 mutation in a sample of 175 Italian cystic fibrosis patients. Hum Genet (1990) 0.99
Uroporphyrinogen 3 cosynthetase activity in fibroblasts from patients with congenital erythropoietic porphyria. Biochem Genet (1970) 0.99
Disorders of the esophageal motor activity in atresia of the esophagus. J Pediatr Surg (1987) 0.98
Residual activity of alpha-galactosidase A in Fabry's disease. Biochem Genet (1975) 0.98
Human alpha-fucosidase. Purification and properties. Biochim Biophys Acta (1976) 0.98
Molecular characterization of human X/Y translocations suggests their aetiology through aberrant exchange between homologous sequences on Xp and Yq. Ann Hum Genet (1989) 0.98
Uroporphyrinogen 3 cosynthetase in asymptomatic carriers of congenital erythpoietic porphyria. Biochem Genet (1970) 0.98
Bilateral neonatal adrenal abscess. Report of two cases and review of the literature. Pediatr Med Chir (2003) 0.97
Retinoic acid is able to induce interferon regulatory factor 1 in squamous carcinoma cells via a STAT-1 independent signalling pathway. Cell Growth Differ (1999) 0.97
X-linkage of human -galactosidase. Nat New Biol (1972) 0.97
A single-nucleotide polymorphic variant of the RET proto-oncogene is underrepresented in sporadic Hirschsprung disease. Eur J Hum Genet (2000) 0.97
The evolution of acid mucopolysaccharides in carrageenin granulomata. Br J Exp Pathol (1967) 0.96
Interstitial deletion of the endothelin-B receptor gene in the spotting lethal (sl) rat. Hum Mol Genet (1995) 0.96
RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma. Oncogene (2000) 0.96
Senescence and cell death pathways and their role in cancer therapeutic outcome. Curr Med Chem (2009) 0.96